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http:WHAT THIS PAPER ADDS
Ethanol embolotherapy has proved to be curative for the treatment of arteriovenous malformations (AVMs).
However, the sole use of absolute ethanol embolization is not suitable for all types of AVMs. This study reports a
single center experience and evaluates technical and clinical safety, and effectiveness of the sole use of absolute
ethanol embolization for inﬁltrating-diffuse extracranial AVMs in the head and neck.Objective: Extracranial arteriovenous malformations (AVMs) of an inﬁltrative type in the head and neck can
cause cosmetic, functional, and psychological problems. This study reports a single center experience and
evaluates the clinical safety and effectiveness of the sole use of absolute ethanol embolotherapy for inﬁltrative
extracranial AVMs in the head and neck.
Method: From June 2011 to June 2013, 168 consecutive patients with extracranial AVMs in the head and neck
underwent staged ethanol or other methods of embolization, of whom 66 patients had inﬁltrating-diffuse
extracranial AVMs of type III in the head and neck. Absolute ethanol embolization was solely used and
retrospectively evaluated. All patients were assessed at clinical follow up (mean 16.8 months; range 12e38
months). Therapeutic outcomes were determined by evaluating the clinical outcome of symptoms and signs, as
well as the degree of devascularization by follow up angiography.
Results: For the 96 sessions, the mean amount of ethanol used in a single embolization session was 13.6 mL and
range was from 2 to 25 mL. Fifty-six of the 66 patients were effectively controlled with 100% of the AVMs
devascularized, and the remaining 10 patients had partial remission with various degrees of AVM
devascularization (50e99%). Transient hemoglobinuria occurred in ﬁve of the 66 patients for a total 16 out of 96
procedures. There were no major complications.
Conclusions: The sole use of ethanol embolotherapy appears to be efﬁcacious and safe in the management of
inﬁltrating-diffuse extracranial AVMs in the head and neck.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Arteriovenous malformations (AVMs) of the extracranial
head and neck can cause tremendous cosmetic, functional,
and psychological problems. Small and superﬁcial AVMs can
be cured by surgical resection; however, most AVMs are
inoperable as they are large and diffuse in nature and they
involve important normal adjacent structures. With im-
provements in catheter technology, superselective tech-
niques, and the use of liquid embolic agents,responding author. Department of Interventional Radiology,
ai Ninth People’s Hospital, Shanghai Jiao Tong University School of
ne, No. 639 Zhi Zao Ju Road, Shanghai 200011, PR China.
il address: fanxindong@aliyun.com (X. Fan).
-5884/ 2015 European Society for Vascular Surgery. Published by
r Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2015.02.020embolotherapy has emerged as the primary mode of
treatment for the management of peripheral AVMs.1e4
Ethanol embolotherapy has proved to be effective, even
in complex AVMs, by a combination of the direct denuding
effect on the vascular wall and clumping of damaged
erythrocytes and denatured proteins, which result in com-
plete and permanent obliteration of the vessel lumen.5e7
However, the sole use of absolute ethanol embolization is
not suitable for all types of AVMs. AVMs were categorized
by Cho et al.8 according to the angiographic morphology of
the nidus: type I (larger arteriovenous ﬁstulae with no more
than three separate arteries shunting to the initial single
venous outﬂow component), type II (smaller arteriovenous
ﬁstulae with multiple arterioles shunting to the initial part
of a plexiform appearance into a single venous component),
type IIIa (arteriovenous ﬁstulae with non-dilated ﬁstulae
with multiple ﬁne shunts present between arterioles and
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ﬁstulae with dilated ﬁstulae with multiple shunts present
between arterioles and the venous component). Similar
angiographic morphology was found in the head and neck
in the present study, although the Cho et al. classiﬁcation
focuses mainly on the trunk and extremities. The present
work beneﬁts from this classiﬁcation, especially for the
absolute ethanol embolization procedure. As a result of the
augmented ﬂow with the increased volume rate of types I
and II arteriovenous ﬁstulae, most of the ethanol was
ﬂushed away by the circulation. Intravascular occlusion coils
within the venous component of the nidus must be used to
reduce the rate and volume of blood ﬂow. Sole absolute
ethanol embolization was not as effective as seen with type
III AVMs. Herein, these are referred to as “inﬁltrating-
diffuse” AVMs.
This study reports outcomes and complications seen in a
series of 66 cases of inﬁltrating-diffuse type III extracranial
AVMs, according to the Cho et al. classiﬁcation, located in
the head and neck which were solely treated with absolute
ethanol embolization.METHODS
Patients
Approval from the institutional review board of the study
hospital was obtained for a retrospective review of patients’
medical and imaging records, and informed patient consent
for the study was also obtained. From June 2011 to June
2013, 168 consecutive patients with extracranial AVMs in
the head and neck underwent staged ethanol embolization
or other methods of embolization, of whom 66 patients
with type III extracranial AVMs were identiﬁed by angiog-
raphy and treated. The study group consisted of 66 patients
(28 males, 38 females) with a mean age of 26.8 years (age
range 16e46 years) at the time of treatment. Diagnosis of
AVMs was made by the referring center on the basis of
clinical and imaging ﬁndings. Eight patients had undergone
previous partial resection or n-Butyl cyanoacrylate emboli-
zation at other hospitals before undergoing ethanol
embolotherapy.
Selective and superselective angiograms were performed
before embolization in all patients to accurately deﬁne the
feeding arteries, draining veins, and nidus of the AVM.Angiographic and embolization techniques
All procedures were performed by two experienced inter-
ventional radiologists. Sixty-six patients with 96 emboliza-
tion procedures received general anesthesia after nasal
intubation. Blood pressure, electrocardiogram, oxygen
saturation, and end tidal carbon dioxide levels were
constantly monitored during the procedures.
To determine the detailed angio-architecture of the
AVMs, selective angiograms of the feeding artery including
facial artery, superﬁcial temporal artery, posterior auricular
artery, or the occipital artery were performed to further
identify the main feeding artery. It was also necessary toidentify any abnormal extracranial and intracranial com-
munications. The major compartments of the AVMs and
endovascular accesses to those compartments were delin-
eated. All angiograms of these AVMs showed tortuous
arteriolar components of the nidus, and arteriovenous
ﬁstulae without obvious dilated outﬂow vein formation.
For the patients whose external carotid arteries were
ligated during prior therapies, angiograms of the common
carotid artery, the vertebral artery, and the thyrocervical
trunk were performed on the same side of the lesions, as
well as the external carotid artery on the opposite side.
Once the feeding vessels of the lesions were identiﬁed, a
microcatheter (Powler10, Cordis Endovascular, Miami Lakes,
FL, USA) was inserted into the nidus. In cases in which these
complex maneuvers failed, a direct puncture of the nidus
was performed. The area of percutaneous puncture was
prepped and draped. A 21 gauge butterﬂy needle was
advanced under the guidance of repeated contrast in-
jections. Super-selective placement of the catheter tip or
the needle tip was a requirement, only then could ethanol
be injected into the nidus with sparing of all normal
vascular structures. Absolute ethanol (99.7%) was used as
the embolization agent. The intention was to direct ethanol
towards the nidus itself and not towards the vascular
feeders. Repeated angiograms through the needle were
used to ensure that there was no retrograde ﬂow of
contrast to the proximal part of ophthalmic artery or other
feeding arteries before ethanol injections. The contrast
medium could only be seen in the nidus and outﬂow vein.
The goal was to embolize all or part of the nidus until the
desired clinical results were achieved. For the 96 sessions of
ethanol embolization performed, a solitary transarterial
approach was used in 28 sessions, solitary direct puncture
in 26 sessions, and a combination of both in 42 sessions.
The ethanol was manually injected after several test in-
jections with the contrast medium to determine the pres-
sure required and the amount of ethanol to inject based on
the exact ﬂow characteristics of the AVMs. The amount of
ethanol used during embolization was based on the amount
of contrast medium required to ﬁll the portion of the AVM
being treated. Arteriography was performed 5e10 minutes
after each ethanol injection to determine whether blood
ﬂow stasis had been achieved. Meticulous repetition of the
above described technique was required until complete
embolization of at least one compartment of the AVM was
achieved. Ethanol should not be injected again when the
outﬂow vein disappears and the feeding artery appears
reﬁlled in retrograde fashion. When the direct puncture
embolization was performed, if the injected contrast was
seen out of the vascular nidus and staining normal tissues,
no more ethanol was injected so as to avoid any possible
necrosis. The total amount of absolute ethanol used per
session was less than 1 mL/kg of body weight.
To minimize local soft tissue swelling and accompanying
pain, all patients received an intravenous injection of
dexamethasone prior to the procedure, usually 5e10 mg,
depending on their body weight. Post-operative manage-
ment included an intravenous infusion of dexamethasone.
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corticosteroids over 7 days and Zantac (Sanoﬁ, Hangzhou,
China). Any hemoglobinuria that occurred during the pro-
cedure was managed by means of hydration with an
intravenously administered crystalloid solution. To evaluate
renal function, serum creatinine and urea levels were
measured at least once during the hospital stay.
In some cases with almost 100% devascularization of
abnormal arteriovenous communications as seen on an-
giograms, but which still presented with some degree of
cosmetic problems left by the AVM, further operation was
necessary to correct the contour or function.Table 1. Demographic data of treatment, results, and
complications in 66 patients with 99 procedures.
Parameter Value
Approach
Transarterial 28 (29.2%)
Direct puncture 26 (27.1%)
Combined 42 (43.7%)
Total 96 (100%)
No. of embolization procedures
Total 96
Mean 1.44
Amount of injected ethanol (mL)
Mean (range) 13.6 (2e25)
Degree of devascularization
100% 56 (84.8%)
76e99% 10 (15.2%)
Total 66 (100%)
Complications (SIR classiﬁcation)
No complication 50 (75.8%)Evaluation of clinical data and follow up results
Follow up evaluation was obtained on the basis of physical
examination at 3 month intervals and telephone question-
naire at 1 month intervals in all patients (follow up range
12e38 months; mean 16.8 months) after the initial proce-
dure. Additional embolization was recommended if the
symptoms and signs remained or if the AVMs were still
present on follow up imaging. The results were graded on a
four point scale: worse (AVMs became larger); no change
(AVMs 49% resolved); improved (AVMs were 50e99%
resolved); and effective control (AVMs were 100%
resolved). One oral and maxillofacial surgeon and one
interventional radiologist evaluated the clinical outcome of
symptoms and signs by consensus. Cure was deﬁned as
complete resolution of the clinical symptoms and signs,
with 100% devascularization of AVMs as seen on angiog-
raphy. Partial remission was deﬁned as complete resolution
or improvement of the clinical symptoms and signs, with
50e99% devascularization of AVMs as seen on angiography.
No remission was deﬁned as no improvement or no change
of the clinical symptoms and signs, with less than 50%
devascularization of AVMs as seen on angiography. Aggra-
vation was deﬁned as an aggravation of the clinical symp-
toms and signs, regardless of the degree of AVM
devascularization as seen on angiography. Cure and partial
remission were considered effective therapeutic outcomes
of ethanol embolization of AVMs.
Complications were classiﬁed into major and minor ac-
cording to standards reported by the Society of Interven-
tional Radiology.9 Minor complications were deﬁned as
those that required no management and resulted in no
consequences. Major complications included those that
required therapy or caused permanent adverse sequelae or
death. When complications were observed, the angiograms
were reviewed again to detect the possible cause of the
complications.B 16 (24.2%)
Follow up (mo) (range) 16.8 (12e38)
Complications: Minor Complications: A. No therapy, no
consequence, B. Nominal therapy, no consequence; includes
overnight admission for observation only. Major Complications:
C. Require therapy, minor, hospitalization (48 hours), D. Require
major therapy, unplanned increase in level of care, prolonged
hospitalization (48 hours), E. Permanent adverse sequelae, F.
Death.RESULTS
Clinical outcomes
The post-operative recovery in all the patients was un-
eventful. There was no signiﬁcant bleeding. After the needle
was removed, manual pressure on the puncture site was
performed for 5 minutes until there was no more oozing.After the procedure, patients exhibited focal swelling in the
area of the AVMs, which was resolved within 1e2 weeks.
For the 96 sessions, the mean volume of ethanol used
was 13.6 mL and ranged from 2 mL to 25 mL for a single
embolization session. Even when the maximum amount of
ethanol was used, the total dose did not exceed 1 mL/kg of
body weight. No patient experienced ethanol induced side
effects on the liver and kidneys (measured by appropriate
lab tests). Hemoglobinuria occurred in ﬁve of the 66 pa-
tients for a total of 16 out of 96 sessions, which disappeared
at 5e6 hours after continuous intravenous infusion; no
patient showed elevation in creatinine or urea levels.
As a therapeutic outcome of ethanol embolization, there
was an obvious reduction in redness, swelling, and warmth
in all of the patients. Fifty-six of the 66 patients were cured
with 100% of AVM devascularization, with the remaining 10
having partial remission with various degrees of AVM
devascularization (50e99%).
The required number of embolization procedures in pa-
tients varied depending on the volume and behavior of the
lesion and the adjacent tissues involved. A single emboli-
zation procedure was usually sufﬁcient to achieve cure of
localized AVMs, but diffuse cases involving adjacent soft
tissue required multiple sessions. In patients who needed
two or more procedures, the time interval between the
procedures ranged from 1 to 2 months. The amount of
ethanol used and results of treatment in 66 patients are
summarized in Table 1. Thirteen of the 66 patients had
further operations to correct persisting deformity after the
embolization.
Absolute Ethanol Embolization 117Complications
There was no procedure related mortality. Sixteen of the 66
patients had minor complications classiﬁed as B using the
SIR (Society of Interventional Radiology) classiﬁcation.9
Minor complications included skin blistering or superﬁcial
skin necrosis. Skin blisters, superﬁcial skin necrosis, and
pyogenic granulomas from puncture points were healed
with wound dressing, and skin grafting was not required.
One case with AVMs in the chin had ethanol backﬂow to
the distal part of the facial artery causing superﬁcial skin
necrosis of the buccal area and an obvious but acceptable
scar (Table 1).
Case illustrations
Case 1: A 26 year old male presenting with a red pulsating
mass at the left buccal region was treated successfully with
5 mL absolute ethanol embolization by percutaneous direct
puncture (Fig. 1). The pre-embolization angiogram demon-
strated that the AVMs were supplied mainly by a tortuous
facial artery, and that these were type III (Fig. 2A). A lateral
view of the vein phase of the pre-embolization angiogram
shows an inﬁltrating-diffuse nidus of AVMs and outﬂow
vein (Fig. 2B). Because of the tortuous facial artery, the
microcatheter failed to reach the center of the nidus ofFigure 1. Anterior lateral view (A) and anterior supine view (C) of a 28 y
region. Obvious shrinkage of AVM mass in the left buccal region was sh
month after ethanol embolization (D).AVMs. A 21 gauge butterﬂy needle was used to directly
puncture the nidus. Contrast medium was injected to make
sure that there was no backﬂow to the feeding arteries
before ethanol injection, and then followed by a total of
5.0 mL absolute ethanol given in increments
(2.0 mL þ 2.0 mL þ 1.0 mL) (Fig. 2C). Arteriography was
performed 5 minutes after each ethanol injection to
determine whether thrombosis had occurred. Ethanol
should not be injected again when the outﬂow vein dis-
appears and the feeding artery appears (Fig. 2D). A lateral
view of the angiogram of the facial artery shows complete
obliteration of AVMs and the outﬂow veins (Fig. 3).
Case 2: A 36 year old female presenting with an AVM in
the buccal region was treated successfully with two pro-
cedures of absolute ethanol embolization
(15.0 mL þ 3.0 mL) (Fig. 4A and B).
Case 3: A 22 year old male presenting with AVM at the
lower lip and buccal area was treated successfully with one
procedure of absolute ethanol embolization (8.0 mL)
(Fig. 5A and B).DISCUSSION
AVMs in the extracranial head and neck regions are rare and
challenging entities. Surgical treatment is the classicear old male presenting with a pulsating red mass in the left buccal
own on the anterior lateral view (B) and the anterior supine view 1
Figure 2. (A) Lateral view of the pre-embolization angiogram showed AVMs mainly supplied by a tortuous facial artery (arrow). (B) Lateral
view of the venous phase of the pre-embolization angiogram showed inﬁltrating-diffuse nidus (short arrow) of AVMs and outﬂow vein
(long arrow). (C) Direct puncture of the nidus was performed. The area of percutaneous puncture was prepped and draped. A 21 gauge
butterﬂy needle was used for puncture (arrow). The contrast medium was injected through a needle to make sure that there was no
backﬂow of contrast to the proximal part of facial arteries before ethanol injection, followed by absolute ethanol injection three times in
increments (2.0 mL þ 2.0 mL þ 1.0 mL). (D) Arteriography through the 21 gauge butterﬂy needle was performed 5 minutes after each
ethanol injection to determine whether thrombosis had occurred. Ethanol should not be injected again when the outﬂow vein disappears
and the feeding artery appears (arrow).
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ligation of the feeding arteries or by attempted excision
after embolization, but such procedures have not been very
successful.
With the development of interventional radiology,
embolotherapy is playing an ever increasing role in the
management of AVMs. There are many embolic agents for
use in various clinical scenarios, with the choice of agent
depending on several factors: the vascular territory to be
treated, the type of abnormality being treated, the possi-
bility of superselective delivery of an occlusive agent, the
goal of the procedure, and the permanence of the occlusion
required. With regards to vascular malformations, perma-
nent treatment is a signiﬁcant issue. It has already been
documented in the literature that embolization with ma-
terials such as polyvinyl alcohol (PVA), tissue adhesives, and
coils is rarely curative and provides only temporary pallia-
tion.10e13 The main reason for recanalization and neo-
vascular recruitment is that none of the aforementioned
embolic agents completely destroys the endothelial cells inthe nidus of the AVMs. These may sense decreased oxygen
tension, resulting in the release of angiogenesis factors that
stimulate neovascular formation and release of chemotactic
substances that cause cellular inﬁltration contributing to
the removal of debris from the vascular channels.14 Once
this happens recanalization occurs and previously embol-
ized vessels re-endothelialize.
With the use of absolute ethanol, the endothelial cells
are denuded from the vascular wall, its protoplasm is
precipitated, and a fracture in the vascular wall at the
level of the internal elastic lamina is formed, followed by
shrinking of the lesion.9,15,16 In AVMs, these changes are
desirable and responsible for the curative effects and
permanence of ethanol embolization. This is quite impor-
tant for AVMs of the face, considering the aesthetic as-
pects. The judicious use of ethanol as an embolic agent
has revolutionized the ability to permanently cure these
lesions in soft tissues, organs, bone, and brain as
described in 1994 by Coldwell, Yakes, and multiple other
authors.17
Figure 3. Lateral view of the angiogram of the facial artery showed
complete obliteration of AVMs and the outﬂow veins.
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used, sole absolute ethanol embolization cannot achieve
good results in all extracranial AVMs in the head and neck.
In some high ﬂow cases with a dominant outﬂow vein
(DOV), the injected ethanol may become diluted with blood
and may be swept away from the nidus before it causes
nidus occlusion. Thus, ﬂow occlusion techniques, including
external pneumatic pressure cuffs and intravascular occlu-
sion balloon catheter or coil embolization of the DOV, are
sometimes required to achieve effective ethanol emboli-
zation of this subset of peripheral AVMs, as described by
Jackson, Cho, and Yakes.18e20
Angiographic classiﬁcation of AVMs as described by Cho
et al. provides a useful classiﬁcation for AVM treatment,
especially for absolute ethanol embolization. Although theirFigure 4. (A) Lateral view of the venous phase of the pre-embolization a
arrow) of AVMs and outﬂow vein (long arrow). (B) Lateral view of ang
and the outﬂow veins.classiﬁcation mainly focuses on the trunk and extremities,
this classiﬁcation is useful in the study of AVMs in face and
neck, with similar ﬁndings on angiographic morphology.
Based on this classiﬁcation system, most of the AVM cases
in the present study were mixed types and good results
were obtained with ethanol embolization.
Another reason for the sole use of ethanol to embolize
the type III inﬁltrating-diffuse extracranial AVMs in the head
and neck, is that cosmetic corrections should be considered.
Most inﬁltrating-diffuse AVMs in this region present as
facial masses with superﬁcial skin involvement. Obvious
shrinkage of the AVM mass and cosmetic improvement can
be achieved after absolute ethanol embolization. Polymer-
izing liquid agents such as nBCA and ONYX have commonly
been used; however, they cannot cause shrinkage of the
AVM’s mass like that caused by ethanol. Meanwhile, most
inﬁltrating-diffuse AVMs in this region are superﬁcial and
skin is involved in the lesion. When coils lie very superﬁ-
cially, they can erode through the overlying skin and cause
ulceration, and in addition, patients can feel some
discomfort because of the mass effect. In some cases of
AVMs with DOV, if coils have to be used to reduce the ﬂow
speed and volume of DOV, extraction of these coils is
required during the follow up period.
Complications are one of the most important issues for
interventional radiologists when treating AVMs with abso-
lute ethanol, and cardiovascular collapse is the most severe
complication related to it. There was a case of cardiovas-
cular collapse during ethanol embolization for a type I AVM
of the upper lip, not in this group, and the patient died with
DIC 2 days after cardio-pulmonary resuscitation was suc-
cessfully performed. No relationship was found between
cardiovascular collapse and the dosage or method of in-
jection of ethanol.21 To avoid such complications it is critical
that the dose per kilogram and per 10 minutes is no more
than 0.14 mL/kg. This is well documented in previous
publications by Young So Do.22ngiogram showed inﬁltrating-diffuse nidus in the buccal area (short
iogram of the facial artery showed complete obliteration of AVMs
Figure 5. (A) Lateral view of the venous phase of the pre-embolization angiogram showed inﬁltrating-diffuse nidus in the lower lip (arrow)
of AVMs. (B) Lateral view of the angiogram of the facial artery showed complete obliteration of AVMs and the outﬂow veins.
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zation for type III AVMs has a lower incidence of cardio-
vascular collapse than for type I or type II. The main
complication that should be considered when using ethanol
to treat inﬁltrating-diffuse extracranial AVMs in the head
and neck is local skin necrosis and ectopic embolism of a
normal artery. Non-target embolization with ethanol will
lead to tissue necrosis as capillary beds are entirely
destroyed. Being a ﬂuid agent, ethanol penetrates to the
capillary level, devitalizing normal tissues. Skin blisters, su-
perﬁcial skin necrosis, and pyogenic granulomas were the
most common complications in the present study, but these
healed well with wound dressings and no scars were left.
Only one case with AVMs in the chin had ethanol backﬂow
to the distal part of the facial artery causing skin necrosis of
buccal area and an obvious but acceptable scar.
Although ethanol is one of the strongest embolization
agents known, it must be remembered that ethanol is also
an extremely dangerous intravascular sclerosant that can
cause total tissue devitalization and neuropathy. In the face
and neck area it is important to be aware of all communi-
cations that exist between the internal and external carotid
artery domains.23,24 The internal carotid artery, which
supplies the supraorbital area, nasal dorsum, and forehead,
communicates with the external carotid artery along the
suborbital area and paranasal skin. These communications
are of clinical importance, as they may open and lead to
non-target embolization of the ophthalmic artery, with
possible visual dysfunction or blindness. The backﬂow of
ethanol from the occipital artery to the spinal artery should
be monitored when treating AVMs in the occipital scalp
region.CONCLUSION
Ethanol is one of the strongest embolization agents and can
cause severe complications if not properly used. The pre-
sent study demonstrated that the sole use of ethanol for
embolization is efﬁcacious and safe in the management ofinﬁltrating-diffuse extracranial AVMs in the head and neck.
Through transarterial embolization or direct puncture
embolization, the nidus within the AVMs can be reached
and completely obliterated in one or more sessions by the
controlled delivery of absolute ethanol.
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